2025 HCPCS Code Q0173
Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
TAGS: therapeutic dosage exceed complete trimethobenzamide substitute chemotherapy approved regimen prescription| Short Description | Trimethobenzamide hcl 250mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | April 01, 1998 |
| HCPCS Action Effective Date | April 01, 1998 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4273 - Esano aaa, per sq cm
- Q4274 - Esano ac, per sq cm
- Q4275 - Esano aca, per sq cm
- Q4276 - Orion, per sq cm
- Q4277 - Woundplus e-grat, per sq cm
- Q4278 - Epieffect, per sq cm
- Q4279 - Vendaje ac, per sq cm
- Q4280 - Xcell amnio matrix per sq cm
- Q4281 - Barrera slor dl per sq cm
- Q4282 - Cygnus dual per sq cm
- Q4283 - Biovance tri or 3l, sq cm
- Q4284 - Dermabind sl, per sq cm
- Q4285 - Nudyn dl or dl mesh pr sq cm
- Q4286 - Nudyn sl or slw, per sq cm
- Q4287 - Dermabind dl, per sq cm
- Q4288 - Dermabind ch, per sq cm
- Q4289 - Revoshield+ amnio, per sq cm
- Q4290 - Membrane wrap hydr per sq cm
- Q4291 - Lamellas xt, per sq cm
- Q4292 - Lamellas, per sq cm